You are here

Retrospective Epidemiology Study Of ALK Rearrangement In Non-Small Cell Lung Cancer Patients In The Middle East & North Africa

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
National Cancer Institute
Cairo / Misr Al Qadimah, , Egypt
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Non-small Cell Lung Cancer
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- 1. Histological confirmation of nonsquamous NSCLC, with any TNM stage. 2. Available and
sufficient tissue sample for ALK testing 3.Tissue samples are less than 5 years old
4.Routinely processed formalin-fixed, paraffin-embedded tissue samples only (see exclusion
criteria pertaining to tissue samples).

5.Histological sections mounted on glass slides must not be older than 3 months 6.Age > 18
years 7.Any ECOG Performance status 8.Still alive, or death confirmed before inclusion, or
is unknown 9.Disease diagnosis and/or treatment in one of the centers, in the last 5 years,
assigned to participate in the study; 10.Written informed consent for general
investigational testing was previously obtained, or specifically obtained for this
retrospective epidemiology study, or having a documented waiver for the Informed consent
document use, as required by local regulatory authorities, &/or Research Ethics
committee/Institutional Review Board.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- 1- Tumor tissue samples older than 5 year period or samples not properly stored.

2-Tumor tissue samples fixed by using AFA, B5, Bouin's, 95% ETOH, & alcohol fixatives.

3-Under-fixed tissue samples (i.e. subject to any decalcification processes. 5-Recycled paraffin-embedded tissue samples.
6-Cut slides stored longer than 3 months. 7-Insufficient tissue samples with less
tumor cells & high amount of necrosis.

NCT02304406
Pfizer
Completed
Retrospective Epidemiology Study Of ALK Rearrangement In Non-Small Cell Lung Cancer Patients In The Middle East & North Africa

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Non-small Cell Lung Cancer
NCT03844464
All Genders
0+
Years
Tokyo,
Pancreatic Cancer, Non-Small Cell Lung Cancer, Cancer
NCT03637491
All Genders
18+
Years
Multiple Sites
Non-Small Cell Lung Cancer, Urothelial Cancer
NCT03472560
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now